Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.

Tytuł :
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Autorzy :
Barry M; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
AlMohaya A; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
AlHijji A; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Akkielah L; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
AlRajhi A; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Almajid F; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Alsharidi A; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Al-Shahrani FS; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Alotaibi NH; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Alanazi A; Division of Infectious Disease, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ghonem L; Department of Pharmacy, King Saud University Medical City, Riyadh, Saudi Arabia.
Alhetheel A; Microbiology Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Alsubaie S; Pediatrics Infectious Disease Unit, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Memish ZA; Director Research and Innovation Centre, King Saud Medical City, Ministry of Health & College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Pokaż więcej
Źródło :
Journal of epidemiology and global health [J Epidemiol Glob Health] 2020 Sep; Vol. 10 (3), pp. 214-221.
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Publication: [2018]- : [Paris, France] : Atlantis Press
Original Publication: Amsterdam : Elsevier, [2011]-[2018]
MeSH Terms :
Middle East Respiratory Syndrome Coronavirus*
Coinfection/*epidemiology
Coronavirus Infections/*epidemiology
Endemic Diseases/*statistics & numerical data
Hospitalization/*statistics & numerical data
Pandemics/*statistics & numerical data
Pneumonia, Viral/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Saudi Arabia/epidemiology ; Young Adult
References :
Lancet. 2020 May 30;395(10238):1695-1704. (PMID: 32401715)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
Cell Res. 2020 Mar;30(3):269-271. (PMID: 32020029)
N Engl J Med. 2012 Nov 8;367(19):1814-20. (PMID: 23075143)
J Infect Public Health. 2020 Jul;13(7):920-925. (PMID: 32534945)
J Med Virol. 2020 Jul;92(7):791-796. (PMID: 32181911)
J Epidemiol Glob Health. 2020 Mar;10(1):1-3. (PMID: 32175703)
Thorax. 2018 Mar;73(3):286-289. (PMID: 28724637)
Science. 2020 May 29;368(6494):1012-1015. (PMID: 32303590)
Lancet Infect Dis. 2020 May 19;:. (PMID: 32442522)
Lancet. 2020 Jun 6;395(10239):1763-1770. (PMID: 32442528)
Infection. 2020 Apr;48(2):241-248. (PMID: 31873850)
N Engl J Med. 2020 May 21;382(21):2012-2022. (PMID: 32227758)
BMJ. 2020 May 22;369:m1985. (PMID: 32444460)
Clin Infect Dis. 2020 Jul 28;71(15):732-739. (PMID: 32150618)
Liver Int. 2020 Sep;40(9):2095-2103. (PMID: 32239796)
JAMA. 2020 May 26;323(20):2052-2059. (PMID: 32320003)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Open Forum Infect Dis. 2020 Apr 29;7(5):ofaa153. (PMID: 32455147)
J Thromb Haemost. 2020 Apr;18(4):844-847. (PMID: 32073213)
Ann Intern Med. 2003 Nov 4;139(9):715-23. (PMID: 14597455)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
JAMA Intern Med. 2020 Jul 1;180(7):934-943. (PMID: 32167524)
J Intern Med. 2020 Sep;288(3):335-344. (PMID: 32352202)
Immunol Res. 2001;24(2):163-76. (PMID: 11594454)
JAMA. 2020 Jun 2;323(21):2195-2198. (PMID: 32329797)
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. (PMID: 32105090)
Contributed Indexing :
Keywords: COVID-19; SARS-CoV-2; Saudi Arabia; clinical; outcome
SCR Disease Name :
COVID-19
Entry Date(s) :
Date Created: 20200921 Date Completed: 20200930 Latest Revision: 20200930
Update Code :
20201023
PubMed Central ID :
PMC7509106
DOI :
10.2991/jegh.k.200806.002
PMID :
32954712
Czasopismo naukowe
Background: The Kingdom of Saudi Arabia (KSA) reported 170,639 cases and 1430 deaths from COVID-19 since the first case emerged in the country on March 2 through June 25, 2020. The objective of this report is to describe the characteristics and outcome observed among 99 hospitalized COVID-19 patients in the largest academic hospital in KSA, and assess co-infection with the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Methods: This single-center case series data included select epidemiological, clinical, radiological features and laboratory findings of all confirmed hospitalized cases of COVID-19 in King Saud University Medical City (KSUMC), Riyadh, KSA, from March 22 until May 31, 2020, followed through June 6, 2020. We conducted retrospective analysis of listed data from 99 hospitalized patients and present characteristics and factors associated with severity in percentages and univariate odds ratios. Cases were confirmed using nasopharyngeal or throat swab by real-time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and MERS-CoV by RT-PCR.
Results: The 99 hospitalized COVID-19 patients included in this analysis constitute 16% of 632 positive SARS-CoV-2 among 6633 persons who were tested at the KSUMC (positivity rate, 9.4%). MERS-CoV PCR was negative in all 99 patients tested. The majority of these 99 hospitalized patients were males (66%), had a mean age of 44 years (range, 19-87), and a quarter (25.3%) were health care workers. Patients with comorbid conditions accounted for 52.5% of patients including the 8.1% who were asymptomatic; diabetes mellitus being the most frequent (31.3%), followed by hypertension (22.2%). The most common presenting symptoms were fever (67.7%), cough (60.6%), dyspnea (43.4%), upper respiratory symptoms (27.3%), fatigue (26.3%), diarrhea (19.2%) and loss of smell (9.1%). The clinical conditions among these 99 patients included upper respiratory tract infection (47.5%), abnormal chest X-ray, lymphopenia, high inflammatory markers a fifth (21%) of patients had moderate pneumonia, while 7% had severe pneumonia with 22.2% requiring admission to the intensive care unit and 12.1% died. Late presentation with severe disease, an abnormal chest X-ray, lymphopenia, high inflammatory markers (C-reactive protein, ferritin, and procalcitonin), and end organ damage (high creatinine or high aspartate aminotransferase) were predictors for admission to critical care unit or died.
Conclusion: We observed no MERS-CoV co-infection in this early cohort of hospitalized COVID-19 patients who were relatively young, more than half had comorbid conditions, presented with fever and/or cough, an abnormal chest X-ray, lymphopenia, and high inflammatory markers. Given MERS-CoV endemicity in the country, co-monitoring of MERS-CoV and SARS-CoV-2 coinfection is critical.
(© 2020 The Authors. Published by Atlantis Press International B.V.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies